Development of specification for substance 7-azepan-1- il-1-ethil-6-ftor-3- (4-phenyl-1, 3-tiazol-2-il) - Quinoline- 4 (1h)-one

Abstract

The paper presents the results of the development of specifications for a new first-synthesized chemical compound exhibiting antibacterial activity and positioned as a perspective drug substance. According to the recommendations of the European Pharmacopoeia quality control procedures have been developed for standardization the substance of 7-azepan-1-yl-1-ethyl-6-fluoro-3-(4-phenyl-1,3-thiazol-2-yl))- quinoline-4(1H)-one - a modified derivative of the fluoroquinolone series.